SCHEMBL8949704

SCHEMBL8949704

Cc1cc(-c2ccc(F)cc2)c(C(O)O)c(C)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
KDM4E B2RXH2 2/20 0.43
MAPT P10636 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
HMGCR P04035 2/20 0.40
POLB P06746 1/20 0.39
STAT1 P42224 1/20 0.38
ADORA2A P29274 1/20 0.37
ADORA2B P29275 1/20 0.37
ADORA1 P30542 1/20 0.37
DHODH Q02127 2/20 0.37
GCGR P47871 2/20 0.35
GRM2 Q14416 1/20 0.35
MAPK1 P28482 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GAA P10253 1/20 0.35
APP P05067 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8949790 0.84 GCGR (0.40) NPC1RAB9ASMN1; SMN2KDM4EMAPT
SCHEMBL10511491 0.84 NPC1 (0.43) NPC1RAB9ASMN1; SMN2KDM4EMAPT
SCHEMBL6956576 0.75 GCGR (0.46) NPC1RAB9ASMN1; SMN2KDM4EMAPT
SCHEMBL8949830 0.72 GCGR (0.45) GCGR
SCHEMBL10424693 0.71 NPC1 (0.43) NPC1RAB9ASMN1; SMN2KDM4EMAPT
SCHEMBL8051661 0.71 MEN1 (0.51) NPC1RAB9ASMN1; SMN2KDM4EMAPT
SCHEMBL6956685 0.71 HMGCR (0.51) NPC1RAB9ASMN1; SMN2KDM4EMAPT
SCHEMBL6956421 0.71 NPC1 (0.43) NPC1RAB9ASMN1; SMN2KDM4EMAPT
SCHEMBL9270449 0.70 SMN1; SMN2 (0.51) NPC1RAB9ASMN1; SMN2KDM4EDHODH
SCHEMBL10588746 0.69 GCGR (0.52) NPC1RAB9ASMN1; SMN2KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5502057-A Polysubstituted pyridines useful for treating lipoproteinanaemia and arteriosclerosis BAYER AKTIENGESELLSCHAFT (DE) 1996-03-26 US disclosed
US-5470982-A Disubstituted pyridines BAYER AKTIENGESELLSCHAFT (DE) 1995-11-28 US disclosed
US-5173495-A 7-[(2,6-dialkyl-4-furyl or thienyl-pyridyl)]-3,5-di-(dihydroxy-6-enoates) useful for treating circulatory diseases BAYER AKTIENGESELLSCHAFT (DE) 1992-12-22 US disclosed
US-4968689-A Certain 2,6-diisopropyl-4-(4-fluoro-phenyl)-3,5-bis-dimethyl-3',5'-dihydroxy-hept-6-enoate-pyridine derivatives useful for treating lipoproteinaemia and arteriosclerosis BAYER AKTIENGESELLSCHAFT (DE) 1990-11-06 US disclosed
CN-1034716-A Disubstituted pyridines and preparation method thereof BAYER AG (DE) 1989-08-16 CN disclosed